Replication to Enhance Research Impact Initiative

The Replication to Enhance Research Impact Initiative supports independent replication of high-significance biomedical studies and external validation of promising technologies, with a mechanism designed to strengthen result reliability across Common Fund programs and broader NIH-supported research streams. Researchers are supported through Notices NOT-RM-24-009 and NOT-RM-24-013 for preparatory work such as protocol and reagent exchange, while Contract Research Organizations can access separate funding to execute the replication studies. The initiative also reports a Replication Prize, with winners publicly announced in a ceremony on May 13, 2026, and is described as active with a two-track operational model. The strongest fit is teams with mature experimental designs and clean reproducibility plans that can be clearly separated into preparation and execution phases. This is a grant route anchored in methodology transparency, rigorous protocol sharing, and close alignment between primary investigators and external execution partners.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.